Janku, Filip <br/><br/>
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.  [electronic resource] 

 -  Oncotarget  May 2014 
 - 3012-22 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.1687  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Hepatocellular--drug therapy<br/>Female<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--physiology<br/>TOR Serine-Threonine Kinases--metabolism